Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple Myeloma

OBJECTIVE: Multiple myeloma (MM) is characterized by the accumulation and proliferation of malignant plasma cells, secreting monoclonal immunoglobulins and genetic abnormalities in MM have implications for disease progression and survival. In the present study, we investigated the frequency of chrom...

Full description

Bibliographic Details
Main Authors: Beyhan Durak Aras, Olga Meltem Akay, Gülçin Sungar, Güney Bademci, Vahap Aslan, Jülide Caferler, Muhsin Özdemir, Oğuz Çilingir, Sevilhan Artan, Zafer Gülbaş
Format: Article
Language:English
Published: Galenos Publishing House 2012-05-01
Series:Turkish Journal of Hematology
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-24993
_version_ 1797916902880706560
author Beyhan Durak Aras
Olga Meltem Akay
Gülçin Sungar
Güney Bademci
Vahap Aslan
Jülide Caferler
Muhsin Özdemir
Oğuz Çilingir
Sevilhan Artan
Zafer Gülbaş
author_facet Beyhan Durak Aras
Olga Meltem Akay
Gülçin Sungar
Güney Bademci
Vahap Aslan
Jülide Caferler
Muhsin Özdemir
Oğuz Çilingir
Sevilhan Artan
Zafer Gülbaş
author_sort Beyhan Durak Aras
collection DOAJ
description OBJECTIVE: Multiple myeloma (MM) is characterized by the accumulation and proliferation of malignant plasma cells, secreting monoclonal immunoglobulins and genetic abnormalities in MM have implications for disease progression and survival. In the present study, we investigated the frequency of chromosomal abnormalities (CA) in Turkish patients with MM, using interphase FISH and CC and evaluated the relationship between the rearrangements detected, prognosis and stage of disease. METHODS: We performed conventional cytogenetic and FISH studies in 50 patients to detect chromosome anomalies associated with MM. FISH probes were used to detect 13q14, 13q34, 17p13 deletions, IGH rearrangements, and monosomy and/or trisomy of chromosomes 5, 9, and 15. RESULTS: CC studies could be performed in 32 of 50 cases and five patients (15.6%) showed chromosomal aberrations while 27 (84.3%) had normal karyotypes. By FISH, eighteen percent (9/50) of cases were found to be normal for all parameters evaluated. Eighty-two percent (41/50) of the patients were positive for at least one abnormality. Chromosome 13 anomalies were detected in 54% (27/50) of cases. The second most common aberration observed is chromosome 15 aberrations (50%). CONCLUSION: Median survival rate was shorter in patients with one of the abnormalities including chromosome 13 aberrations, IGH rearrangements or P53 deletions. Chromosome 15 aberrations were significantly higher in patients with stage III disease (p=0.02). We conclude that FISH studies should be performed in conjunction with conventional cytogenetic analysis for prognosis in multiple myeloma patients.
first_indexed 2024-04-10T13:04:42Z
format Article
id doaj.art-3ed158a9a8f643929c7d05ec7f5a8a99
institution Directory Open Access Journal
issn 1308-5263
language English
last_indexed 2024-04-10T13:04:42Z
publishDate 2012-05-01
publisher Galenos Publishing House
record_format Article
series Turkish Journal of Hematology
spelling doaj.art-3ed158a9a8f643929c7d05ec7f5a8a992023-02-15T16:13:00ZengGalenos Publishing HouseTurkish Journal of Hematology1308-52632012-05-0129213514210.5152/tjh.2011.42TJH-24993Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple MyelomaBeyhan Durak Aras0Olga Meltem Akay1Gülçin Sungar2Güney Bademci3Vahap Aslan4Jülide Caferler5Muhsin Özdemir6Oğuz Çilingir7Sevilhan Artan8Zafer Gülbaş9Eskisehir Osmangazi University, Medical Faculty, Department Of Medical Genetics, Eskisehir, TurkeyEskisehir Osmangazi University, Medical Faculty, Department Of Hematology, Eskisehir, TurkeyEskisehir Osmangazi University, Medical Faculty, Department Of Medical Genetics, Eskisehir, TurkeyEskisehir Osmangazi University, Medical Faculty, Department Of Medical Genetics, Eskisehir, TurkeyYunus Emre State Hospital, Department Of Hematology, Eskisehir, TurkeyGenetiks Genetic Diagnosis Center, Istanbul, TurkeyEskisehir Osmangazi University, Medical Faculty, Department Of Medical Genetics, Eskisehir, TurkeyEskisehir Osmangazi University, Medical Faculty, Department Of Medical Genetics, Eskisehir, TurkeyEskisehir Osmangazi University, Medical Faculty, Department Of Medical Genetics, Eskisehir, TurkeyEskisehir Osmangazi University, Medical Faculty, Department Of Hematology, Eskisehir, TurkeyOBJECTIVE: Multiple myeloma (MM) is characterized by the accumulation and proliferation of malignant plasma cells, secreting monoclonal immunoglobulins and genetic abnormalities in MM have implications for disease progression and survival. In the present study, we investigated the frequency of chromosomal abnormalities (CA) in Turkish patients with MM, using interphase FISH and CC and evaluated the relationship between the rearrangements detected, prognosis and stage of disease. METHODS: We performed conventional cytogenetic and FISH studies in 50 patients to detect chromosome anomalies associated with MM. FISH probes were used to detect 13q14, 13q34, 17p13 deletions, IGH rearrangements, and monosomy and/or trisomy of chromosomes 5, 9, and 15. RESULTS: CC studies could be performed in 32 of 50 cases and five patients (15.6%) showed chromosomal aberrations while 27 (84.3%) had normal karyotypes. By FISH, eighteen percent (9/50) of cases were found to be normal for all parameters evaluated. Eighty-two percent (41/50) of the patients were positive for at least one abnormality. Chromosome 13 anomalies were detected in 54% (27/50) of cases. The second most common aberration observed is chromosome 15 aberrations (50%). CONCLUSION: Median survival rate was shorter in patients with one of the abnormalities including chromosome 13 aberrations, IGH rearrangements or P53 deletions. Chromosome 15 aberrations were significantly higher in patients with stage III disease (p=0.02). We conclude that FISH studies should be performed in conjunction with conventional cytogenetic analysis for prognosis in multiple myeloma patients.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-24993cytogenetcismyelomafishchromosomal aberrations
spellingShingle Beyhan Durak Aras
Olga Meltem Akay
Gülçin Sungar
Güney Bademci
Vahap Aslan
Jülide Caferler
Muhsin Özdemir
Oğuz Çilingir
Sevilhan Artan
Zafer Gülbaş
Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple Myeloma
Turkish Journal of Hematology
cytogenetcis
myeloma
fish
chromosomal aberrations
title Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple Myeloma
title_full Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple Myeloma
title_fullStr Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple Myeloma
title_full_unstemmed Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple Myeloma
title_short Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple Myeloma
title_sort conventional and molecular cytogenetic analyses in turkish patients with multiple myeloma
topic cytogenetcis
myeloma
fish
chromosomal aberrations
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-24993
work_keys_str_mv AT beyhandurakaras conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma
AT olgameltemakay conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma
AT gulcinsungar conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma
AT guneybademci conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma
AT vahapaslan conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma
AT julidecaferler conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma
AT muhsinozdemir conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma
AT oguzcilingir conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma
AT sevilhanartan conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma
AT zafergulbas conventionalandmolecularcytogeneticanalysesinturkishpatientswithmultiplemyeloma